Table 5.
Characteristics associated with weight gain (≥5% baseline value), from baseline to 12 months after chemotherapy, fitting a logistic regression model: odds ratios (ORs) and corresponding 95% confidence intervals (CIs)
| Characteristic | No. (%) with weight gain/total | OR | 95% CI | p |
|---|---|---|---|---|
| Age (years) | 0.94 | 0.90–0.98 | 0.015 | |
| Hormone therapy | ||||
| No | 6/56 (10.7) | Reference | ||
| Yes | 26/113 (23.0) | 3.26 | 1.06–10 | 0.04 |
| Baseline weight | ||||
| Overweight/obesity | 3/67 (4.5%) | Reference | ||
| Normal weight/underweight | 29/102 (28.4) | 10.56 | 2.59–43 | 0.001 |
| MDS T0–T6 | ||||
| Stable/improvement | 24/151 (15.9) | Reference | ||
| Worsening | 8/18 (44.4) | 7.08 | 1.94–25 | 0.003 |
| Physical activity frequency T0–T6 | ||||
| Stable/increase | 22/143 (15.4) | Reference | ||
| Decrease | 10/26 (38.5) | 4.90 | 1.59–15 | 0.006 |
MDS Mediterranean Diet Score [19]